Volume 14 Issue 8, August 2000

Programmed cell death regulation: basic mechanisms and therapeutic opportunities

• DE Johnson

Mini Review 04 Aug 2000

Duration of second complete remission compared with first complete remission in patients with acute myeloid leukemia

• S Lee
• MS Tallman
• JM Rowe

Original Manuscript 04 Aug 2000

Low-dose cytarabine maintenance therapy vs observation after remission induction in advanced acute myeloid leukemia: an Eastern Cooperative Oncology Group Trial (E5483)

• C Robles
• KM Kim
• PA Cassileth

Original Manuscript 04 Aug 2000

Pilot studies of species-specific chemotherapy of childhood acute lymphoblastic leukemia using genotype and immunophenotype

• R Manera
• I Ramirez
• D Pinkel

Original Manuscript 04 Aug 2000

Double induction strategy including high dose cytarabine in combination with all-trans retinoic acid: effects in patients with newly diagnosed acute promyelocytic leukemia

• E Lengfelder
• A Reichert
• T Büchner

Original Manuscript 04 Aug 2000

Long-term follow-up confirms the benefit of all-trans retinoic acid in acute promyelocytic leukemia

• P Fenaux
• S Chevret
• L Degos

Original Manuscript 04 Aug 2000

Erythropoietic reconstitution, macrophages and reticulin fibrosis in bone marrow specimens of CML patients following allogeneic transplantation

• J Thiele
• HM Kvasnicka
• UW Schaefer

Original Manuscript 04 Aug 2000

Participation of granulocyte colony-stimulating factor in the growth regulation of leukemia cells from Philadelphia chromosome-positive acute leukemia and blast crisis of chronic myeloid leukemia

• T Inukai
• K Sugita
• S Nakazawa

Original Manuscript 04 Aug 2000

Combination of interferon alpha with either Ara-C or ATRA in vitro reduces the selective action of interferon against CML CFU-GM

• SB Marley
• RJ Davidson
• MY Gordon

Original Manuscript 04 Aug 2000

Increase in mutant frequencies in mice expressing the BCR-ABL activated tyrosine kinase

• HF Salloukh
• P Laneuville

Original Manuscript 04 Aug 2000

Inhibition of RNA transcription: a biochemical mechanism of action against chronic lymphocytic leukemia cells by fludarabine

• P Huang
• A Sandoval
• W Plunkett

Original Manuscript 04 Aug 2000

Increased bone marrow angiogenesis in B cell chronic lymphocytic leukemia

• AR Kini
• NE Kay
• LC Peterson

Original Manuscript 04 Aug 2000

Improved assessment of minimal residual disease in B cell malignancies using fluorogenic consensus probes for real-time quantitative PCR

• M Brüggemann
• J Droese
• M Kneba

Original Manuscript 04 Aug 2000

Application of germline IGH probes in real-time quantitative PCR for the detection of minimal residual disease in acute lymphoblastic leukemia

• OJHM Verhagen
• MJ Willemse
• CE van der Schoot

Original Manuscript 04 Aug 2000

Calicheamicin-conjugated humanized anti-CD33 monoclonal antibody (gemtuzumab zogamicin, CMA-676) shows cytocidal effect on CD33-positive leukemia cell lines, but is inactive on P-glycoprotein-expressing sublines

• K Naito
• A Takeshita
• R Ohno

Original Manuscript 04 Aug 2000

Increased sensitivity of multidrug-resistant myeloid leukemia cell lines to lovastatin

• L Maksumova
• K Ohnishi
• R Ohno

Original Manuscript 04 Aug 2000

Cytotoxic and clastogenic effects of a DNA minor groove binding methyl sulfonate ester in mismatch repair deficient leukemic cells

• L Tentori
• P Vernole
• G Graziani

Original Manuscript 04 Aug 2000

Role of the membrane form of human colony-stimulating factor-1 (CSF-1) in proliferation of multipotent hematopoietic FDCP-Mix cells expressing human CSF-1 receptor

• I Tsuboi
• V Revol
• G Mouchiroud

Original Manuscript 04 Aug 2000

Rapid tumor formation and development of neutrophilia and splenomegaly in nude mice transplanted with human cells expressing human T cell leukemia virus type I or Tax1

• Y Soda
• A Jinno
• H Hoshino

Original Manuscript 04 Aug 2000

Inhibition of angiogenesis and induction of endothelial and tumor cell apoptosis by green tea in animal models of human high-grade non-Hodgkin's lymphoma

• F Bertolini
• L Fusetti
• G Pruneri

Original Manuscript 04 Aug 2000

Mantle cell lymphoma proliferates upon IL-10 in the CD40 system

• HPJ Visser
• M Tewis
• JC Kluin-Nelemans

Original Manuscript 04 Aug 2000

BCL10 is not the gene inactivated by mutation in the 1p22 deletion region in mantle cell lymphoma

• L Bullinger
• E Leupolt
• S Stilgenbauer

Original Manuscript 04 Aug 2000

The detection of contaminating clonal cells in apheresis products is related to response and outcome in multiple myeloma undergoing autologous peripheral blood stem cell transplantation

• R López-Pérez
• R García-Sanz
• JF San Miguel

Original Manuscript 04 Aug 2000

Spotlight on apoptosis

• MV Blagosklonny

Spotlight Introduction 04 Aug 2000

Cell death beyond apoptosis

• MV Blagosklonny

Spotlight Review 04 Aug 2000

Death and decoy receptors and p53-mediated apoptosis

• MS Sheikh
• AJ Fornace Jr

Spotlight Review 04 Aug 2000

The most unkindest cut of all: on the multiple roles of mammalian caspases*

• B Fadeel
• S Orrenius
• B Zhivotovsky

Spotlight Review 04 Aug 2000

Quantitative analysis of TEL/AML1 fusion transcripts by real-time RT-PCR assay in childhood acute lymphoblastic leukemia

• P Ballerini
• J Landman Parker
• I Bièche

Correspondence 04 Aug 2000

The common deletion 657del5 in the Nibrin gene is not a major risk factor for B or T cell non-Hodgkin lymphoma in a pediatric population

• J Rischewski
• P v Bismarck
• R Schneppenheim

Correspondence 04 Aug 2000

Overexpression of heat shock protein 60 and the survival of blast in acute myeloid leukemia after induction therapy

• I Emura
• T Chou
• M Arakawa

Correspondence 04 Aug 2000

Quantitation of PML-RARα transcripts in APL patients

• K Tobal

Correspondence 04 Aug 2000

Response

• B Cassinat
• C Chomienne

Correspondence 04 Aug 2000